Orphan drugs are developed to serve small, highly specific patient populations. They represent some of the most innovative and patient-critical therapies in the pharmaceutical industry. Yet despite their uniqueness, many orphan drugs are still forced through secondary packaging processes designed for mass-market pharmaceuticals, and that mismatch can quietly undermine efficiency, cost control, and patient access.
As rare disease pipelines expand, it’s time to say:
Most conventional packaging facilities are optimized for scale. High-volume campaigns, long production runs, and rigid scheduling make sense for massmarket drugs but orphan drugs operate under an entirely different reality.
Orphan drugs are not simply “smaller versions” of mass-market therapies. They demand a packaging approach built around:
The traditional packaging lines often require high minimum batch sizes to justify setup and operation. For orphan drugs with limited and variable demand, this can mean overproduction, unnecessary inventory, and increased financial risk.
Applying a one-size-fits-all packaging model to rare deseases therapies forces unnecessary compromises and losses.
Recognizing the gap between the common CDMO packaging offer and the unmeet orphan drugs pharma needs, we opened the brand new packaging workshop designed specifically for Orphan Drug Products, that we called “FlexiPack”. This new semi-automatic packaging line is dedicated for small-batches like those for orphan drugs or clinical trial materials.
This is not a scaled-down version of a mass-market line. It’s a fundamentally different approach based on:
We package to actual patient demand, not arbitrary minimums dictated by oversized equipment. This eliminates the burden of high minimum order quantities, reduces waste, and improves inventory control.
Whether you need rapid market entry or responsive replenishment, our FlexiPack Line rule #1 is to support agility at every stage.
Advanced, tailored semi-automation ensures compliant, reliable packaging every time with lower operational risk while maintaining the highest standards of accuracy and quality.
Stop compromising. Let’s build a packaging strategy as specialized, agile, and patient-centric as your therapy. To learn more about our FlexiPack line, please contact us by filling the form here below.